newsfilter
← Latest News
Business Wire·

Aptar Announces CE Marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine Developers

Milestone strengthens Aptar Pharma’s support for intranasal vaccine development from clinical studies through commercialization Aptar Pharma, part of AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery,